The Spain peptide anticoagulant drugs market growth continues to demonstrate resilience as the country's robust biotechnology and pharmaceutical sector accelerates research into novel peptide-based antithrombotic molecules that address unmet needs in heparin resistance, antiphospholipid syndrome, and cancer-associated thrombosis. Spanish research institutions including the Centro Nacional de...